Mapping quantitative trait loci that influence serum insulin-like growth factor binding protein-5 levels in F2 mice (MRL/MpJ x SJL/J)

被引:12
作者
Mohan, S
Masinde, G
Li, XM
Baylink, DJ
机构
[1] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA
[2] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Dept Biochem, Loma Linda, CA 92350 USA
[4] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA
关键词
D O I
10.1210/en.2003-0042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent studies using twins and inbred strains of mice reveal evidence for genetic mechanisms contributing to variation in circulating levels of IGF-I, IGF-II, and IGF binding protein (IGFBP)-3. To examine the hypothesis that serum IGFBP-5 levels have a strong heritable component, we intercrossed two inbred strains of mice, MRL/MpJ and SJL, which exhibit 79% difference in serum IGFBP-5 levels (554 +/- 68 vs. 309 +/- 51 ng/ml respectively, P < 0.001). A genome-wide scan was carried out using 137 polymorphic markers in 633 F2 female mice. Serum IGFBP-5 levels in the F2 progeny showed a normal distribution with an estimated heritability of 74%. Whole genome-wide scans for cosegregation of genetic marker data with high or low serum IGFBP-5 levels revealed six different quantitative trait loci (QTL) in chromosomes 1, 9 (two), 10, and 11 (two), which together explained 24% of F2 variance. Chromosome 11 QTL exhibited the highest LOD score (7.5). Based on the past findings that IGFBP-5 is an important bone formation stimulator, we predicted IGFBP-5 to contribute to bone mineral density variation in F2 mice. Accordingly, we found two of the six IGFBP-5 QTLs (Chrs 1 and 11) identified for serum IGFBP-5 phenotype also showed significant association with total body bone mineral density phenotype (measured by dual energy x-ray absorptiometry) in the F2 mice.
引用
收藏
页码:3491 / 3496
页数:6
相关论文
共 40 条
[1]   IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice [J].
Andress, DL .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (02) :E283-E288
[2]  
ANDRESS DL, 1992, J BIOL CHEM, V267, P22467
[3]   The complex of recombinant human insulin like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration [J].
Bauss, F ;
Lang, K ;
Dony, C ;
Kling, L .
GROWTH HORMONE & IGF RESEARCH, 2001, 11 (01) :1-9
[4]   Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis [J].
Boonen, S ;
Mohan, S ;
Dequeker, J ;
Aerssens, J ;
Vanderschueren, D ;
Verbeke, G ;
Broos, P ;
Bouillon, R ;
Baylink, DJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (12) :2150-2158
[5]   Serum levels of insulin-like growth factor binding proteins in Ecuadorean children with growth hormone insensitivity [J].
Burren, CP ;
Wanek, D ;
Mohan, S ;
Cohen, P ;
Guevara-Aguirre, J ;
Rosenfeld, RG .
ACTA PAEDIATRICA, 1999, 88 :185-191
[6]   The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium [J].
Busby, WH ;
Nam, TJ ;
Moralez, A ;
Smith, C ;
Jennings, M ;
Clemmons, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (48) :37638-37644
[7]   Role of insulin-like growth factor binding proteins in controlling IGF actions [J].
Clemmons, DR .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 140 (1-2) :19-24
[8]   GROWTH-HORMONE DEFICIENCY IN LITTLE MICE RESULTS IN ABERRANT BODY-COMPOSITION, REDUCED INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3 (IGFBP-3), BUT DOES NOT AFFECT IGFBP-2, IGFBP-1 OR IGFBP-4 [J].
DONAHUE, LR ;
BEAMER, WG .
JOURNAL OF ENDOCRINOLOGY, 1993, 136 (01) :91-104
[9]  
Ewton DZ, 1998, J CELL PHYSIOL, V177, P47, DOI 10.1002/(SICI)1097-4652(199810)177:1<47::AID-JCP5>3.0.CO
[10]  
2-E